The pyrin inflammasome in FMF patients is mostly controlled at the step1 level (pyrin dephosphorylation) (Magnotti et al., 2019), likely explaining why the response to steroid catabolites (acting primarily on the step 2) is not drastically affected by FMF-associated MEFV mutations. The gene discussed is MEFV; the disease is familial Mediterranean fever.